The agenda features a mix of clinical updates and lively debates on provocative scientific topics in the field, including emerging concepts and therapies in multiple myeloma, lymphoma, acute and chronic lymphocytic leukemia, myeloid malignancies, and much more.

July 27-28 | Los Angeles

Available DatesRegister

Saturday July 27, 2024

  • 8:00 AM – 8:05 AM

    Welcome

    • Co-Chair
      • John LeonardMD
  • 8:05 AM – 8:20 AM

    Session 1: Debate- Chemotherapy-Based Approaches Are Best for Initial Therapy for Mantle Cell Lymphoma

    • Speaker
      • Elizabeth BremMD
  • 8:20 AM – 8:35 AM

    Session 1: Debate- Novel, Non-chemotherapy Approaches are Best for Initial Therapy for Mantle Cell Lymphoma

    • Speaker
      • Tycel PhillipsMD
  • 8:35 AM – 8:45 AM

    Session 1: PANEL DISCUSSION

    • Moderator
      • John LeonardMD
    • Panelist
      • Elizabeth BremMD
      • Tycel PhillipsMD
  • 8:45 AM – 9:00 AM

    Session 2: Debate-Should Older Patients with Relapsed DLBCL Receive CAR-T Cell Therapy?

    • Speaker
      • Mazyar ShadmanMD, MPH
  • 9:00 AM – 9:15 AM

    Session 2: Debate-Should Older Patients with Relapsed DLBCL Receive Novel Agents?

    • Speaker
      • Elizabeth BremMD
  • 9:15 AM – 9:25 AM

    Session 2: PANEL DISCUSSION

    • Moderator
      • John LeonardMD
    • Panelist
      • Elizabeth BremMD
      • Mazyar ShadmanMD, MPH
  • 9:25 AM – 9:55 AM

    Session 3: Reevaluating Frontline Therapy and Beyond for Hodgkin Lymphoma: Strategies for Optimal Clinical Decision-Making and Targeted Therapy Across Patient Groups

    • Speaker
      • Tycel PhillipsMD
  • 9:55 AM – 10:05 AM

    Session 3: Post Session Survey and Q&A

    • Moderator
      • John LeonardMD
    • Speaker
      • Tycel PhillipsMD
  • 10:05 AM – 10:15 AM

    Exhibit Hall Break

View Full Agenda